Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy
Internet Cognitive Behavioral Therapy for Depression
N/A
Waitlist Available
Led By Xiaoling Xiang, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
have at least mild depressive symptoms, based on PHQ-9 >=5
≥50 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline phq-9 at 10 weeks
Awards & highlights
Study Summary
This trial will test a new online therapy for depression in 300 older adults in Michigan. The 10-week program will be compared to a control group to see if it is effective.
Who is the study for?
This trial is for Michigan residents over 50 with mild depression, as indicated by a PHQ-9 score of at least 5. It's not suitable for those with active suicidal thoughts, terminal illness, severe vision impairment without help, probable cognitive impairment, non-English speakers, or recent substance abuse issues.Check my eligibility
What is being tested?
The study tests Empower@Home—an internet-based cognitive behavioral therapy program designed to reduce depressive symptoms in older adults. The intervention lasts about 10 weeks and aims to demonstrate improved mood post-treatment.See study design
What are the potential side effects?
Since this is a psychological therapy program delivered online, there are no direct medical side effects like you'd expect from medication; however, participants may experience emotional discomfort addressing mental health issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I experience mild or more severe depression symptoms.
Select...
I am 50 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline phq-9 at 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline phq-9 at 10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Patient Health Questionnaire-9 (PHQ-9)
Modified Treatment Evaluation Inventory
Secondary outcome measures
Change in Duke Social Support Index (DSSI)-10
Change in Generalized Anxiety Disorder Assessment-7 (GAD-7)
Change in PROMISE-SI
Trial Design
1Treatment groups
Experimental Treatment
Group I: Internet-based programExperimental Treatment1 Intervention
Participants will be provided with access to a 9-session online program and will receive supportive remote assistance throughout regarding technical and programmatic issues.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Empower@Home
2022
N/A
~10
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,795 Previous Clinical Trials
6,373,696 Total Patients Enrolled
67 Trials studying Depression
68,883 Patients Enrolled for Depression
Xiaoling Xiang, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
70 Total Patients Enrolled
1 Trials studying Depression
70 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe vision problems and no one to help me use a mobile device.You have a history of drug or alcohol abuse within the past year and scored at least 2 on the 4-item CAGE screener.I experience mild or more severe depression symptoms.I do not speak English.I am 50 years old or older.You are willing to be part of the study.
Research Study Groups:
This trial has the following groups:- Group 1: Internet-based program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Depression Patient Testimony for trial: Trial Name: NCT05384704 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are investigators presently accepting new participants for this research endeavor?
"Affirmative. The information found on clinicaltrials.gov reveals that this experiment is actively enrolling participants, with the original posting date of May 23rd 2022 and most recent update occurring June 7th 2022. A total of 300 people are required to partake in the study at one specific site."
Answered by AI
What is the current limit of participants in this experiment?
"Affirmative. Clinicaltrials.gov records demonstrate that this clinical trial is still recruiting participants, commencing on May 23rd 2022 and lastly amended on June 7th 2022. The study seeks to enrol 300 individuals at a single facility."
Answered by AI
Who else is applying?
What state do they live in?
Ohio
New York
Other
Michigan
How old are they?
18 - 65
What site did they apply to?
University of Michigan
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
2
Why did patients apply to this trial?
I’m on medication that is helping but I’m not sure it’s really the right one.
PatientReceived no prior treatments
What questions have other patients asked about this trial?
Is there monetary compensation?
PatientReceived 2+ prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger